About Arvaya Healthcare Limited
Data last updated:
Arvaya Healthcare Limited is a public limited company based in Gmc, Assam, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN L86100AS1985PLC002323. Its GSTIN is 27AABCB2505K1ZX (Maharashtra). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 524723.
The company has an authorised share capital of ₹200 Cr and a paid-up capital of ₹48.02 Cr. It was formerly known as Bijoy Hans Limited. It is led by directors including Kaushal Uttam Shah (Managing Director) and Rahul Ravindra Mayur.
Its last annual general meeting (AGM) was held on 25 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Gmc, Assam.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹9.11 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹89 Lakh (net margin 9.8%) and EBITDA of ₹73 Lakh (EBITDA margin 8%). The net worth stands at ₹63.07 Cr (up 1686.7% YoY). Total assets are valued at ₹113.85 Cr (up 3125.2% YoY).
The company is associated with 1 brand: Bijoy Hans Limited. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bijoyhans.net.
Company details
CIN history
Arvaya Healthcare has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L86100AS1985PLC002323, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L86100AS1985PLC002323 | Current |
| L51909AS1985PLC002323 | Previous |
| U51909AS1985PTC002323 | Previous |
Contact details
Arvaya Healthcare Limited's registered office is in Gmc, Assam.
- Registered AddressNirvana Co Working Spaces Mezzanine Floor, Itag Plaza Abc G S Road Guwahati, Gmc, Assam, India – 781005
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Arvaya Healthcare operates one associated brand: Bijoy Hans Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations manufacturing and related services in Guwahati, India. | bijoyhans.net |
Business activity
The main business activity of Arvaya Healthcare is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Arvaya Healthcare Limited, buy the company report.
Financials of Arvaya Healthcare Limited
FY 2025-26 filings availableArvaya Healthcare Limited reported revenue of ₹9.11 Cr (up 3153.6% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Income statement | ||
| Revenue | 9.11 | 0.28 |
| Revenue growth | +3153.6% | - |
| EBITDA | 0.73 | (0.53) |
| EBITDA margin | +8.0% | -189.3% |
| Profit before tax | 1.08 | 0.19 |
| Net profit | 0.89 | (0.48) |
| Net profit margin | +9.8% | -171.4% |
| EPS (₹) | 0.19 | 0.45 |
| Balance sheet | ||
| Total assets | 114 | 3.53 |
| Net worth | 63.07 | 3.53 |
| Total debt | 49.38 | 0.00 |
| Cash & bank | 2.35 | 2.71 |
| Net working capital | 11.32 | 2.93 |
| Cash flow | ||
| Cash from operations | (3.28) | 0.22 |
| Cash from investing | (5.58) | 0.92 |
| Cash from financing | 8.50 | (0.06) |
| Particulars | Jun 2026 | Mar 2026 | Jun 2025 |
|---|---|---|---|
| Revenue | 29.91 | 9.11 | 0.00 |
| Other income | 0.19 | 1.30 | 0.03 |
| EBITDA | 3.97 | 1.39 | (0.29) |
| EBITDA margin | +13.3% | +15.3% | - |
| Depreciation | 2.20 | 0.62 | 0.00 |
| Interest | 1.39 | 0.41 | 0.00 |
| Profit before tax | 0.57 | 1.66 | (0.26) |
| Tax | 0.03 | 0.19 | 0.00 |
| Net profit | 0.54 | 1.47 | (0.26) |
| EPS (₹) | 0.08 | 1.25 | (0.53) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 0.00 | 0.28 | 0.28 | 0.30 | 0.33 | 0.40 | 0.49 |
| Revenue growth | -100.0% | 0.0% | -6.7% | -9.1% | -17.5% | -18.4% | - |
| EBITDA | (1.37) | 0.03 | (0.36) | (0.51) | (0.30) | (0.27) | (0.23) |
| EBITDA margin | - | +10.7% | -128.6% | -170.0% | -90.9% | -67.5% | -46.9% |
| Profit before tax | (1.20) | 0.19 | (0.12) | (0.44) | (0.18) | (0.10) | (0.04) |
| Net profit | (1.20) | (0.43) | (0.26) | (0.44) | (0.18) | (0.10) | (0.04) |
| Net profit margin | - | -153.6% | -92.9% | -146.7% | -54.6% | -25.0% | -8.2% |
| EPS (₹) | (1.18) | 0.45 | (0.39) | (1.48) | (0.63) | (0.30) | (0.18) |
| Balance sheet | |||||||
| Total assets | 60.51 | 3.53 | 3.45 | 3.59 | 3.95 | 4.14 | 4.23 |
| Net worth | 57.99 | 3.53 | 3.39 | 3.51 | 3.95 | 4.14 | 4.23 |
| Total debt | 2.52 | 0.00 | 0.06 | 0.08 | 0.00 | 0.00 | 0.00 |
| Cash & bank | 0.02 | 2.71 | 1.63 | 1.62 | 1.91 | 2.28 | 2.29 |
| Net working capital | (0.26) | 2.93 | 1.82 | 1.80 | 2.76 | 2.76 | 2.98 |
| Cash flow | |||||||
| Cash from operations | (7.89) | 0.22 | (0.29) | (0.26) | (0.37) | (0.01) | (0.07) |
| Cash from investing | (2.33) | 0.92 | 0.32 | (0.11) | 0.00 | 0.00 | (0.01) |
| Cash from financing | 7.53 | (0.06) | (0.02) | 0.08 | 0.00 | 0.00 | (0.02) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.06 |
| Revenue growth (YoY) | - | - | -100.0% | -100.0% | -100.0% | - | - | - |
| Other income | 0.06 | 0.07 | 0.05 | 0.02 | 0.03 | 0.05 | 0.61 | 0.04 |
| Total expenses | 0.90 | 0.70 | 0.21 | 0.33 | 0.29 | 0.19 | 0.20 | 0.23 |
| EBITDA | (0.80) | (0.70) | (0.21) | (0.33) | (0.29) | (0.19) | (0.07) | (0.17) |
| EBITDA margin | -800.0% | - | - | - | - | - | -53.8% | -283.3% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Interest | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Profit before tax | (0.88) | (0.63) | (0.16) | (0.31) | (0.26) | (0.15) | 0.53 | (0.14) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Jun 2025 |
|---|---|---|---|
| Revenue | 29.91 | 9.11 | 0.00 |
| Other income | 0.19 | 1.30 | 0.03 |
| EBITDA | 3.97 | 1.39 | (0.29) |
| EBITDA margin | +13.3% | +15.3% | - |
| Depreciation | 2.20 | 0.62 | 0.00 |
| Interest | 1.39 | 0.41 | 0.00 |
| Profit before tax | 0.57 | 1.66 | (0.26) |
| Tax | 0.03 | 0.19 | 0.00 |
| Net profit | 0.54 | 1.47 | (0.26) |
| EPS (₹) | 0.08 | 1.25 | (0.53) |
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Revenue | 9.11 | 0.28 |
| Revenue growth | +3153.6% | - |
| Other income | 1.40 | 0.75 |
| Total expenses | 8.38 | 0.81 |
| Employee cost | 1.90 | 0.16 |
| EBITDA | 0.73 | (0.53) |
| EBITDA margin | +8.0% | -189.3% |
| Depreciation | 0.62 | 0.02 |
| Interest | 0.43 | 0.01 |
| Profit before tax | 1.08 | 0.19 |
| Tax | 0.19 | 0.06 |
| Net profit | 0.89 | (0.48) |
| Net profit margin | +9.8% | -171.4% |
| EPS (₹) | 0.19 | 0.45 |
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Equity & liabilities | ||
| Share capital | 48.02 | 3.00 |
| Reserves & surplus | 11.88 | 0.53 |
| Shareholders' funds (net worth) | 63.07 | 3.53 |
| Minority interest | 0.00 | 0.00 |
| Secured loans | 8.60 | 0.00 |
| Unsecured loans | 40.78 | 0.00 |
| Total debt | 49.38 | 0.00 |
| Total liabilities | 114 | 3.53 |
| Assets | ||
| Gross block | 105 | 0.00 |
| Net block | 92.04 | 0.00 |
| Capital work in progress | 0.00 | 0.00 |
| Investments | 0.16 | 0.13 |
| Inventories | 1.90 | 0.00 |
| Sundry debtors | 2.20 | 0.00 |
| Cash & bank balances | 2.35 | 2.71 |
| Loans & advances | 31.64 | 0.28 |
| Total current assets | 38.09 | 2.99 |
| Total current liabilities | 26.77 | 0.06 |
| Net working capital | 11.32 | 2.93 |
| Total assets | 114 | 3.53 |
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Opening cash | 2.71 | 1.63 |
| Net cash from operating activities | (3.28) | 0.22 |
| Net cash from investing activities | (5.58) | 0.92 |
| Net cash from financing activities | 8.50 | (0.06) |
| Net change in cash | (0.36) | 1.08 |
| Closing cash | 2.35 | 2.71 |
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Growth | ||
| Sales growth | +3153.6% | - |
| EBITDA growth | +237.7% | - |
| PBT growth | +468.4% | +9997.0% |
| Net income growth | +285.4% | - |
| Profitability & leverage | ||
| Net income margin | +9.8% | +46.4% |
| Return on capital employed | +2.6% | -10.9% |
| Return on net worth | +2.7% | -13.3% |
| Debt / equity | 0.74 | 0.00 |
| Long-term debt / equity | 0.65 | 0.00 |
| Interest cover | 390.91 | -1.82 |
| Efficiency & per share | ||
| Fixed asset turnover | 0.17 | 0.00 |
| Inventory turnover | 9.59 | 0.00 |
| Debtors turnover | 8.28 | 0.00 |
| EPS (₹) | 0.19 | 0.45 |
| Dividend per share (₹) | 0.00 | 0.00 |
| Book value per share (₹) | 12.47 | 11.76 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.06 |
| Revenue growth (YoY) | - | - | -100.0% | -100.0% | -100.0% | - | - | - |
| Other income | 0.06 | 0.07 | 0.05 | 0.02 | 0.03 | 0.05 | 0.61 | 0.04 |
| Total expenses | 0.90 | 0.70 | 0.21 | 0.33 | 0.29 | 0.19 | 0.20 | 0.23 |
| EBITDA | (0.80) | (0.70) | (0.21) | (0.33) | (0.29) | (0.19) | (0.07) | (0.17) |
| EBITDA margin | -800.0% | - | - | - | - | - | -53.8% | -283.3% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Interest | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Profit before tax | (0.88) | (0.63) | (0.16) | (0.31) | (0.26) | (0.15) | 0.53 | (0.14) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.28 | 0.28 | 0.30 | 0.33 | 0.40 | 0.49 |
| Revenue growth | -100.0% | 0.0% | -6.7% | -9.1% | -17.5% | -18.4% | - |
| Other income | 0.17 | 0.19 | 0.30 | 0.14 | 0.15 | 0.21 | 0.24 |
| Total expenses | 1.37 | 0.25 | 0.64 | 0.81 | 0.63 | 0.67 | 0.72 |
| Employee cost | 0.00 | 0.16 | 0.16 | 0.18 | 0.17 | 0.17 | 0.17 |
| EBITDA | (1.37) | 0.03 | (0.36) | (0.51) | (0.30) | (0.27) | (0.23) |
| EBITDA margin | - | +10.7% | -128.6% | -170.0% | -90.9% | -67.5% | -46.9% |
| Depreciation | 0.00 | 0.02 | 0.05 | 0.06 | 0.03 | 0.04 | 0.05 |
| Interest | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (1.20) | 0.19 | (0.12) | (0.44) | (0.18) | (0.10) | (0.04) |
| Tax | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net profit | (1.20) | (0.43) | (0.26) | (0.44) | (0.18) | (0.10) | (0.04) |
| Net profit margin | - | -153.6% | -92.9% | -146.7% | -54.6% | -25.0% | -8.2% |
| EPS (₹) | (1.18) | 0.45 | (0.39) | (1.48) | (0.63) | (0.30) | (0.18) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 48.02 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Reserves & surplus | 9.97 | 0.53 | 0.39 | 0.51 | 0.95 | 1.14 | 1.23 |
| Shareholders' funds (net worth) | 57.99 | 3.53 | 3.39 | 3.51 | 3.95 | 4.14 | 4.23 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 2.52 | 0.00 | 0.06 | 0.08 | 0.00 | 0.00 | 0.00 |
| Total debt | 2.52 | 0.00 | 0.06 | 0.08 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 60.51 | 3.53 | 3.45 | 3.59 | 3.95 | 4.14 | 4.23 |
| Assets | |||||||
| Gross block | 0.00 | 0.00 | 1.37 | 1.68 | 1.64 | 1.64 | 1.63 |
| Net block | 0.00 | 0.00 | 0.40 | 0.76 | 0.71 | 0.74 | 0.77 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 60.78 | 0.13 | 0.38 | 0.20 | 0.14 | 0.05 | 0.05 |
| Inventories | 0.00 | 0.00 | 0.05 | 0.04 | 0.07 | 0.10 | 0.05 |
| Sundry debtors | 0.00 | 0.00 | 0.08 | 0.09 | 0.08 | 0.13 | 0.17 |
| Cash & bank balances | 0.02 | 2.71 | 1.63 | 1.62 | 1.91 | 2.28 | 2.29 |
| Loans & advances | 7.57 | 0.28 | 0.10 | 0.09 | 0.74 | 0.28 | 0.51 |
| Total current assets | 7.59 | 2.99 | 1.86 | 1.84 | 2.80 | 2.79 | 3.02 |
| Total current liabilities | 7.85 | 0.06 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 |
| Net working capital | (0.26) | 2.93 | 1.82 | 1.80 | 2.76 | 2.76 | 2.98 |
| Total assets | 60.51 | 3.53 | 3.45 | 3.59 | 3.95 | 4.14 | 4.23 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 2.71 | 1.63 | 1.62 | 1.91 | 2.28 | 2.29 | 2.40 |
| Net cash from operating activities | (7.89) | 0.22 | (0.29) | (0.26) | (0.37) | (0.01) | (0.07) |
| Net cash from investing activities | (2.33) | 0.92 | 0.32 | (0.11) | 0.00 | 0.00 | (0.01) |
| Net cash from financing activities | 7.53 | (0.06) | (0.02) | 0.08 | 0.00 | 0.00 | (0.02) |
| Net change in cash | (2.69) | 1.08 | 0.01 | (0.29) | (0.37) | (0.02) | (0.10) |
| Closing cash | 0.02 | 2.71 | 1.63 | 1.62 | 1.91 | 2.28 | 2.29 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -100.0% | 0.0% | -6.7% | -9.1% | -17.5% | -18.4% | - |
| EBITDA growth | -4666.7% | +108.3% | +29.4% | -70.0% | -11.1% | -17.4% | - |
| PBT growth | - | +9998.0% | +72.7% | -144.4% | -80.0% | -150.0% | +42.9% |
| Net income growth | -179.1% | -65.4% | +40.9% | -144.4% | -80.0% | -150.0% | - |
| Revenue CAGR (3Y) | -100.0% | -5.3% | -11.2% | -15.1% | -6.2% | -3.1% | -28.3% |
| EBITDA CAGR (3Y) | +39.0% | - | +10.1% | +30.4% | +7.7% | 0.0% | -5.2% |
| Profitability & leverage | |||||||
| Net income margin | - | +46.4% | -42.9% | -146.7% | -54.6% | -25.0% | -8.2% |
| Return on capital employed | - | -10.9% | -7.1% | -11.4% | -4.7% | -2.2% | -1.2% |
| Return on net worth | - | -12.1% | -7.5% | -11.8% | -4.7% | -2.2% | -1.2% |
| Debt / equity | - | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | - | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.00 | 100.00 | -2.44 | -1.75 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.41 | 0.18 | 0.18 | 0.20 | 0.24 | 0.30 |
| Inventory turnover | - | 11.20 | 6.22 | 5.45 | 3.88 | 5.33 | 8.17 |
| Debtors turnover | - | 7.00 | 3.29 | 3.53 | 3.14 | 2.67 | 3.63 |
| EPS (₹) | (1.18) | 0.45 | (0.39) | (1.48) | (0.63) | (0.30) | (0.18) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 11.76 | 11.31 | 11.70 | 13.18 | 13.80 | 14.10 |
To see the full year-wise statements and ratios of Arvaya Healthcare Limited, buy the company report.
Board of directors of Arvaya Healthcare Limited
Arvaya Healthcare has 6 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kaushal Uttam Shah | Managing Director | 26 May 2025 | 1 Years 5 Months | Current |
| Rahul Ravindra Mayur | Director | 28 Jul 2025 | 1 Years 3 Months | Current |
| Salil Sriram Shetty Also directs: Antworks Solutions India Private Limited | Director | 13 Aug 2024 | 2 Years 3 Months | Current |
| Brijesh Jugalkishor Biyani Also directs: Malu Medico Private Limited | Director | 28 Jul 2025 | 1 Years 3 Months | Current |
| Manali Aditya Pandit | Director | 31 Jan 2026 | 0 Years 9 Months | Current |
| Bidari Kotresh Anilkumar | Additional Director | 04 Jul 2026 | 0 Years 4 Months | Current |
Peer comparison
Arvaya Healthcare Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arvaya Healthcare Limitedthis company | ₹9.11 Cr (FY 2026) | ₹89 Lakh | 9.8% | 3153.6% | Gmc, Assam, India | |
| KHK Pharmaceuticals Private Limited | ₹47.22 Lakh (FY 2023) | 183.0% | New Delhi, Delhi, India | |||
| Ocuris Pharmaceuticals Private Limited | ₹46.98 Lakh (FY 2021) | 12.0% | Gurgaon, Haryana, India | |||
| Raciwell Pharma Private Limited | ₹46.82 Lakh (FY 2023) | -55.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Arvaya Healthcare Limited, buy the company report.
Legal cases
Arvaya Healthcare Limited has 4 court cases on record: 3 filed by Arvaya Healthcare, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kokrajhar, Assam | Court case (Motor Vehicle Act) | Filed against the company by State of Assam | Disposed |
| Bombay High Court | Court case (CHS) | Filed by the company against M/S Kems Pharma | Disposed |
| Bombay High Court | Court case (SJ) | Filed by the company against M/S Kems Pharma | Disposed |
| Bombay High Court | Court case (SS) | Filed by the company against M/S Kems Pharma | Disposed |
To see the full case history of Arvaya Healthcare Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arvaya Healthcare Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arvaya Healthcare has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCB2505K1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Arvaya Healthcare Limited, buy the company report.
Recent activity
Arvaya Healthcare Limited has 24 board changes on record since 2008: 6 appointments and 18 cessations. The latest: Bidari Kotresh Anilkumar was appointed as Additional Director on 04 Jul 2026.
15 earlier events are in the company report.
Frequently asked questions
Arvaya Healthcare is an active public limited company based in Gmc, Assam, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 March 1985 (41+ years old) and is registered under CIN L86100AS1985PLC002323. Listed on BSE: 524723.
Arvaya Healthcare reported revenue of ₹9.11 Cr for FY 2025-26 (up 3153.6% YoY) based on consolidated financials.
Arvaya Healthcare has 6 current directors:
- Kaushal Uttam Shah - Managing Director
- Rahul Ravindra Mayur - Director
- Salil Sriram Shetty - Director
- Brijesh Jugalkishor Biyani - Director
- Manali Aditya Pandit - Director
- Bidari Kotresh Anilkumar - Additional Director
The latest financial statements of Arvaya Healthcare on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Arvaya Healthcare is 27AABCB2505K1ZX, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Arvaya Healthcare is L86100AS1985PLC002323. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Arvaya Healthcare is a listed company as per MCA records. Its shares are listed on BSE (code: 524723).
Arvaya Healthcare has 4 court cases on record: 3 filed by the company and 1 filed against it. Most are in the high courts.
Arvaya Healthcare was incorporated on 26 March 1985, making it 41+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Arvaya Healthcare by revenue are KHK Pharmaceuticals Private Limited, Ocuris Pharmaceuticals Private Limited, Raciwell Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Bidari Kotresh Anilkumar was appointed as Additional Director on 04 Jul 2026. Manali Aditya Pandit was appointed as Director on 31 Jan 2026. Kiran Sudhir Kabra ceased to be Additional Director on 24 Nov 2025. Arvaya Healthcare has 24 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
